By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Solasia Pharma K.K. 

28F, Shinagawa Intercity Tower A
2-15-1, Konan, Minato-ku
Tokyo    108-6028  Japan
Phone: 81-3-6717-4448 Fax: n/a



Company News
Solasia Pharma K.K. And Meiji Seika Pharma Announce License And Collaboration Agreement For Darinaparsin (Intravenous Formulation) 1/19/2015 10:02:15 AM
Solasia Pharma K.K. Grabs Global Rights To ZIOPHARM Oncology, Inc. (ZIOP.OB)'s Zinapar For Up To $72.2 Million 8/1/2014 8:32:48 AM
Solasia Pharma K.K. Announces New Executive Leadership, Clinical Activities, and China Operations 2/6/2013 9:35:00 AM
Solasia Pharma K.K. to Start China Clinical Trial of Anti-Nausea Patch Product 2/5/2013 1:58:08 PM
Solasia Pharma K.K. Announces Initiation of Darinaparsin Injection (SP-02) Phase 1 Study 10/26/2011 8:13:39 AM
ZIOPHARM, Inc. and Solasia Pharma K.K. Announce License and Collaboration Agreement for Darinaparsin in Asia 3/7/2011 10:32:35 AM
Solasia Pharma K.K. and Kyowa Hakko Kirin Enter Into a License Agreement for SP-01 (Sancuso(R)) in Asia 3/3/2010 11:17:21 AM
Solasia Pharma K.K. Release: Completion of Phase I Clinical Trial of Sancuso(R) in Japanese Volunteers 10/30/2009 9:30:23 AM
Solasia Announces Office Move 4/1/2009 10:52:44 AM
Clinical Development of Solasia’s First Drug Initiated in Japan – Clinical Trials Also Planned for China 3/9/2009 11:32:38 AM